SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-049702
Filing Date
2023-09-25
Accepted
2023-09-25 16:30:05
Documents
2
Period of Report
2023-09-21

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1559
2 EX-24 vrdn-ex24.htm EX-24 10260
  Complete submission text file 0000950170-23-049702.txt   13529
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Gheuens Sarah (Reporting) CIK: 0001881190 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36483 | Film No.: 231276136